Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells

We used synthetic lethal high-throughput screening to interrogate 23,550 compounds for their ability to kill engineered tumorigenic cells but not their isogenic normal cell counterparts. We identified known and novel compounds with genotype-selective activity, including doxorubicin, daunorubicin, mi...

Ausführliche Beschreibung